Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Feb 19, 2002
Finance
Ebb & Flow
...June 24, 1999, & BioCentury, Dec. 3, 2001). "Lion's Bayer collaboration fanned sky-high expectations," said
DG Bank
...
Read More
BioCentury
|
Feb 26, 2001
Analyst Picks & Changes
Analyst picks & changes
...GeneScan Europe AG (NMarkt:GEP), Freiburg, Germany Business: Supply/Service
DG Bank
analyst Oliver Schlüter downgraded GEP to "reduce"...
Read More
BioCentury
|
Oct 2, 2000
Finance
3Q Financial Markets Review: Happy Birthday
...which has more than E3.5 billion ($3.1 billion) invested in biotech. Christa Bähr, head of
DG Bank
's...
Read More
Items per page:
10
1 - 3 of 3
BioCentury
|
Feb 19, 2002
Finance
Ebb & Flow
...June 24, 1999, & BioCentury, Dec. 3, 2001). "Lion's Bayer collaboration fanned sky-high expectations," said
DG Bank
...
Read More
BioCentury
|
Feb 26, 2001
Analyst Picks & Changes
Analyst picks & changes
...GeneScan Europe AG (NMarkt:GEP), Freiburg, Germany Business: Supply/Service
DG Bank
analyst Oliver Schlüter downgraded GEP to "reduce"...
Read More
BioCentury
|
Oct 2, 2000
Finance
3Q Financial Markets Review: Happy Birthday
...which has more than E3.5 billion ($3.1 billion) invested in biotech. Christa Bähr, head of
DG Bank
's...
Read More
Items per page:
10
1 - 3 of 3
Previous page
Next page